Miridih, a company focused on creating a simple design culture, has successfully raised $15,000,000 in funding. With their flagship products - MiriCanvas, a web-based design solution that allows users to design worry-free, and Bizhouse, an online printing service that saw over 50% growth in 2022 with 1.2 million small business customers - Miridih is making a significant impact in the design industry. This funding will propel Miridih towards their goal of providing a unique platform that combines design, printing, and monetization, aiming to solve all design-related issues from online to offline in a one-stop solution. Embracing a horizontal and free-spirited culture, Miridih values a work environment where employees take the lead, fostering personal and organizational growth. The company is on a mission to create a world where more people can enjoy beautiful design, and they are actively seeking like-minded individuals to join their journey in shaping a more aesthetically pleasing future.
Miridih Secures $15M in Series B Funding to Revolutionize Design Culture
Recently funded 路 $15.0M Series bDesign
Get the full Miridih company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
